Concepedia

Publication | Open Access

SPIRONOLACTONE FOR NONRESOLVING CENTRAL SEROUS CHORIORETINOPATHY

128

Citations

24

References

2015

Year

Abstract

In eyes with persistent SRF due to central serous chorioretinopathy, spironolactone significantly reduced both the SRF and the subfoveal choroidal thickness as compared with placebo.

References

YearCitations

Page 1